Methoxphenidine(MXP) is a dissociative of the diarylethylamine class that has been sold online as a designer drug. Methoxphenidine was first reported in a 1989 patent where it was tested as a treatment for neurotoxic injury.
It is analog of Diphenidine
Other names: Methoxphenidine, 2-MeO-Diphenidine
IUPAC name: 1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine
CAS number: 127529-46-8
Purity: 99,4% min
Appearance: white powder